Determination Of The Efficacy And Side-effect Profile Of Lower Doses Of Intrathecal Morphine In Patients Undergoing Total Knee Arthroplasty

Patrick Hassett, Bilal Ansari, Pachaimuthu Gnanamoorthy, Brian Kinirons, John G Laffey, Patrick Hassett, Bilal Ansari, Pachaimuthu Gnanamoorthy, Brian Kinirons, John G Laffey

Abstract

Background: Intrathecal (IT) morphine provides excellent post-operative analgesia, but causes multiple side effects including nausea and vomiting (PONV), pruritus and respiratory depression, particularly at higher doses. The lowest effective dose of spinal morphine in patients undergoing total knee arthroplasty is not known.

Methods: We evaluated the analgesic efficacy and side effect profile of 100 - 300 μg IT morphine in patients undergoing elective total knee replacement in this prospective, randomized, controlled, double-blind study. Sixty patients over the age of 60 undergoing elective knee arthroplasty were enrolled. Patients were randomized to receive spinal anaesthesia with 15 mg Bupivacaine and IT morphine in three groups: (i) 100 μg; (ii) 200 μg; and (iii) 300 μg.

Results: Both 200 μg and 300 μg IT morphine provided comparable levels of postoperative analgesia. However, patients that received 100 μg had greater pain postoperatively, with higher pain scores and a greater requirement for supplemental morphine. There were no differences between groups with regard to PONV, pruritus, sedation, respiratory depression or urinary retention.

Conclusion: Both 200 μg and 300 μg provided comparable postoperative analgesia, which was superior to that provided by 100 mug IT morphine in patients undergoing total knee arthroplasty. Based on these findings, we recommend that 200 μg IT morphine be used in these patients.

Trial registration: ClinicalTrials.gov Identifier NCT00695045.

Figures

Figure 1
Figure 1
Mean (+/- SEM) postoperative visual analogue scale (VAS) pain score in each group, measured every 4 hours, for the first 24 postoperative hours. * Indicates significantly higher Area under VAS-Time curve compared to the 200 μg and 300 μg IT Morphine groups (P = 0.006, one way ANOVA).
Figure 2
Figure 2
Dot plot of postoperative requirement for supplemental morphine over the first 24 postoperative hours for each patient in each group. The middle line for each group represents the median value. * Indicates significantly higher morphine requirements compared to the 200 μg and 300 μg IT Morphine groups (P = 0.001, Kruskall-Wallis one way ANOVA on ranks).
Figure 3
Figure 3
Incidence of side-effects, including arterial desaturation below 90%, urinary retention, postoperative nausea and vomiting (PONV) and pruritus in each group over the first 24 postoperative hours (P > 0.05, Chi Square, for all comparisons).

References

    1. Bowrey S, Hamer J, Bowler I, Symonds C, Hall JE. A comparison of 0.2 and 0.5 mg intrathecal morphine for postoperative analgesia after total knee replacement. Anaesthesia. 2005;60:449–452. doi: 10.1111/j.1365-2044.2005.04174.x.
    1. Cole PJ, Craske DA, Wheartley RG. Efficacy and respiratory effects of low-dose spinal morphine for post-operative analgesia following knee arthroplasty. Br J Anaest. 2000;85:233–237. doi: 10.1093/bja/85.2.233.
    1. Jacobson L, Chabal C, Brody MC. A dose-response study of intrathecal morphine: efficacy, duration, optimal dose, and side effects. Anesth Analg. 1988;67:1082–1088.
    1. Goodarzi M, Narasimhan RR. The effect of Large-Dose Intrathecal Opioids on the Autonomic Nervous System. Anesth Analg. 2001;93:456–459. doi: 10.1097/00000539-200108000-00043.
    1. Lydon AM, Cooke T, Duggan F, Shorten GD. Delayed postoperative gastric emptying following intrathecal morphine and intrathecal bupivacaine. Can J Anaesth. 1999;46:544–549.
    1. Carpenter RL, Caplan RA, Brown DL, Stephenson C, Wu R. Incidence and risk factors for side effects of spinal anaesthesia. Anesthesiology. 1992;76:906–916. doi: 10.1097/00000542-199206000-00006.
    1. Slappendel R, Weber EWG, Benraad B, van Limbeek J, Dirksen R. Itching after intrathecal morphine. Incidence and treatment. Eur J Anaest. 2000;17:616–621. doi: 10.1046/j.1365-2346.2000.00727.x.
    1. Clergue F, Montembault C, Despierres O, Ghesquiere F, Harari A, Viars P. Respiratory effects of intrathecal morphine after upper abdominal surgery. Anesthesiology. 1984;61:677–685. doi: 10.1097/00000542-198412000-00009.
    1. Glass PS. Respiratory depression following only 0.4 mg of intrathecal morphine. Anesthesiology. 1984;60:256–257. doi: 10.1097/00000542-198403000-00024.
    1. Grattidge P. Nausea and vomiting after major arthroplasty with spinal anaesthesia including morphine: a randomised trial of subhypnotic propofol infusion as prophylaxis. Acta anaesthesiologica Scandinavica. 1998;42:124–127.
    1. Bailey PL, Rhondeau S, Schafer PG, Lu JK, Timmins BS, Foster W, Pace NL, Stanley TH. Dose response pharmacology of intrathecal morphine in human volunteers. Anaesthesiology. 1993;79:49–59. doi: 10.1097/00000542-199307000-00010.
    1. Laffey JG, Flynn N. Low-dose spinal morphine for postoperative analgesia following knee arthroplasty. Br J Anaesth. 2001;86:152–153.
    1. Rathmell JP, Pino CA, Taylor R, Patrin T, Viani BA. Intrathecal morphine for postoperative analgesia: a randomized, controlled, dose-ranging study after hip and knee arthroplasty. Anesth Analg. 2003;97:1452–1457. doi: 10.1213/01.ANE.0000083374.44039.9E.
    1. Horlocker TS. Practice Guidelines for the Prevention, Detection and Management of Respiratory Depression Associated with Neuraxial Opioid Administration: Preliminary Report by ASA Task Force on Neuraxial Anesthesia. ASA Newsletter. 2007;71:24–26.
    1. Gjessing J, Tomlin PJ. Postoperative pain control with intrathecal morphine. Anaesthesia. 1981;36:268–276. doi: 10.1111/j.1365-2044.1981.tb10199.x.
    1. Bailey PL, Lu JK, Pace NL, Orr JA, White JL, Hamber EA, Slawson MH, Crouch DJ, Rollins DE. Effects of intrathecal morphine on the ventilatory response to hypoxia. N Engl J Med. 2000;343:1228–1234. doi: 10.1056/NEJM200010263431705.
    1. Murphy PM, Stack D, Kinirons B, Laffey JG. Optimizing the dose of intrathecal morphine in older patients undergoing hip arthroplasty. Anesth Analg. 2003;97:1709–1715. doi: 10.1213/01.ANE.0000089965.75585.0D.
    1. Mendieta Sanchez JM, Fernandez-Liesa JI, Marco G, Panadero A, Sanchez-Ledesma MJ, Macias A. Efficacy of 0.1 mg of subarachnoid morphine combined with bupivacaine on postoperative analgesia in total hip arthroplasty[Article in Spanish] Rev Esp Anestesiol Reanim. 1999;46:433–437.
    1. Slappendel R, Weber EW, Dirksen R, Gielen MJ, van Limbeek J. Optimization of the dose of intrathecal morphine in total hip surgery: a dose-finding study. Anesth Analg. 1999;88:822–826. doi: 10.1097/00000539-199904000-00026.
    1. Tohda C, Yamaguchi T, Kuraishi Y. Intracisternal injection of opioids induces itch-associated response through mu-opioid receptors in mice. Jpn J Pharmacol. 1997;74:77–82. doi: 10.1254/jjp.74.77.

Source: PubMed

3
Abonner